View More View Less
  • 1 Országos Korányi Tbc- és Pulmonológiai Intézet Budapest Pihenő út 1. 1121
Restricted access

Cross Mark

A légúti gyulladás központi szerepet játszik a krónikus obstruktív tüdőbetegség patofiziológiájában. A cigarettafüst-expozíció a gyulladásos sejtek infiltrációját okozza a légutakban, amely különböző citokinek, kemokinek, proteázok és proinflammatorikus mediátorok felszabadulásához vezet, végül az oxidatív stressz és a proteáz/antiproteáz egyensúly megbomlása a tüdő szöveteinek progresszív károsodását eredményezi. A biomarkerek felhasználhatók a légúti gyulladás és az oxidatív stressz monitorozására, a betegség különböző fenotípusainak elkülönítésére és a terápiás beavatkozások hatékonyságának megítélésére. A kilégzett levegő kondenzátumának gyűjtése egyszerű és teljesen noninvazív módszer a légutakban zajló folyamatok vizsgálatára. A kilégzett levegő kondenzátumában számos biomarker található, többek között a hidrogén-peroxid, citokinek, arachidonsav-metabolitok, nitrogén-oxidok és a pH. A biomarkerek sok esetben igen kis koncentrációban vannak jelen, amely számos analitikai problémát vet fel. A klinikai felhasználhatóság megítélése a mintagyűjtés és a mérési módszerek standardizálása után lesz lehetséges. Orv. Hetil., 2012, 153, 843–851.

  • Mannino, D. M., Buist, A. S.: Global burden of COPD: risk factors, prevalence, and future trends. Lancet, 2007, 370, 765–773.

    Buist A. S. , 'Global burden of COPD: risk factors, prevalence, and future trends ' (2007 ) 370 Lancet : 765 -773.

    • Search Google Scholar
  • Mathers, C. D., Loncar, D.: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med., 2006, 3, e442.

    Loncar D. , 'Projections of global mortality and burden of disease from 2002 to 2030 ' (2006 ) 3 PLoS Med. : e442 -.

    • Search Google Scholar
  • Strausz, J., Böszörményi-Nagy, G., Csekeö, A., et al.: A pulmonológiai intézmények 2009. évi epidemiológiai és működési adatai. Korányi Bulletin, 2010, 2, 2–25. [Hungarian]

    Csekeö A. , 'A pulmonológiai intézmények 2009. évi epidemiológiai és működési adatai ' (2010 ) 2 Korányi Bulletin : 2 -25.

    • Search Google Scholar
  • Barnes, P. J., Chowdhury, B., Kharitonov, S. A., et al.: Pulmonary biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2006, 174, 6–14.

    Kharitonov S. A. , 'Pulmonary biomarkers in chronic obstructive pulmonary disease ' (2006 ) 174 Am. J. Respir. Crit. Care Med. : 6 -14.

    • Search Google Scholar
  • Borrill, Z. L., Roy, K., Singh D.: Exhaled breath condensate biomarkers in COPD. Eur. Respir. J., 2008, 32, 472–486.

    Singh D. , 'Exhaled breath condensate biomarkers in COPD ' (2008 ) 32 Eur. Respir. J. : 472 -486.

    • Search Google Scholar
  • Exhaled biomarkers. In: European Respiratory Monograph. Eds.: Horvath, I., de Jongste, J. C. European Respiratory Society, Sheffield, UK, 2010.

  • Antus, B., Barta I.: Steroid responsiveness in COPD: sputum eosinophilia and exhaled nitric oxide. [Szteroidérzékenység COPD-ben: köpet-eosinophilia és kilégzett nitrogén-monoxid.] Med. Thor., 2010, 63, 284–289. [Hungarian]

    Barta I. , 'Steroid responsiveness in COPD: sputum eosinophilia and exhaled nitric oxide. [Szteroidérzékenység COPD-ben: köpet-eosinophilia és kilégzett nitrogén-monoxid.] ' (2010 ) 63 Med. Thor. : 284 -289.

    • Search Google Scholar
  • Antus, B.: Role of exhaled nitric oxide in predicting steroid response in chronic obstructive pulmonary disease. [A kilégzett nitrogén-monoxid szerepe a krónikus obstruktív tüdőbetegségek szteroidérzékenységének meghatározásában.] Orv. Hetil., 2010, 151, 2083–2088. [Hungarian]

    Antus B. , 'Role of exhaled nitric oxide in predicting steroid response in chronic obstructive pulmonary disease. [A kilégzett nitrogén-monoxid szerepe a krónikus obstruktív tüdőbetegségek szteroidérzékenységének meghatározásában.] ' (2010 ) 151 Orv. Hetil. : 2083 -2088.

    • Search Google Scholar
  • Antus, B., Barta, I., Horvath, I., et al.: Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations. Respirology, 2010, 15, 472–477.

    Horvath I. , 'Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations ' (2010 ) 15 Respirology : 472 -477.

    • Search Google Scholar
  • Fischer, B. M., Pavlisko, E., Voynow, J. A.: Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int. J. Chron. Obstruct. Pulmon. Dis., 2011, 6, 413–421.

    Voynow J. A. , 'Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation ' (2011 ) 6 Int. J. Chron. Obstruct. Pulmon. Dis. : 413 -421.

    • Search Google Scholar
  • Cosio, M. G., Saetta, M., Agusti, A.: Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med., 2009, 360, 2445–2454.

    Agusti A. , 'Immunologic aspects of chronic obstructive pulmonary disease ' (2009 ) 360 N. Engl. J. Med. : 2445 -2454.

    • Search Google Scholar
  • Van der Strate, B. W., Postma, D. S., Brandsma, C. A., et al.: Cigarette smoke-induced emphysema: a role for the B-cells. Am. J. Respir. Crit. Care Med., 2006, 173, 751–758.

    Brandsma C. A. , 'Cigarette smoke-induced emphysema: a role for the B-cells ' (2006 ) 173 Am. J. Respir. Crit. Care Med. : 751 -758.

    • Search Google Scholar
  • Roche, N., Marthan, R., Berger, P., et al.: Beyond corticosteroids: future prospects in the management of inflammation in COPD. Eur. Respir. Rev., 2011, 20, 175–182.

    Berger P. , 'Beyond corticosteroids: future prospects in the management of inflammation in COPD ' (2011 ) 20 Eur. Respir. Rev. : 175 -182.

    • Search Google Scholar
  • Barnes, P. J., Adcock, I. M.: Glucocorticoid resistance in inflammatory diseases. Lancet, 2009, 373, 1905–1917.

    Adcock I. M. , 'Glucocorticoid resistance in inflammatory diseases ' (2009 ) 373 Lancet : 1905 -1917.

    • Search Google Scholar
  • Ito, K., Yamamura, S., Essilfie-Quaye, S., et al.: Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med., 2006, 203, 7–13.

    Essilfie-Quaye S. , 'Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression ' (2006 ) 203 J. Exp. Med. : 7 -13.

    • Search Google Scholar
  • Horvath, I., Hunt, J., Barnes, P. J.: Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J., 2005, 26, 523–548.

    Barnes P. J. , 'Exhaled breath condensate: methodological recommendations and unresolved questions ' (2005 ) 26 Eur. Respir. J. : 523 -548.

    • Search Google Scholar
  • Vass, G., Huszár, E., Barát, E., et al.: Exhaled breath condensate and its analysis – a new method in pulmonology. [A kilégzett levegő kondenzálása és a kondenzátum elemző vizsgálata. Új módszer a tüdőgyógyászatban.] Orv. Hetil., 2003, 144, 2517–2524. [Hungarian]

    Barát E. , 'Exhaled breath condensate and its analysis – a new method in pulmonology. [A kilégzett levegő kondenzálása és a kondenzátum elemző vizsgálata. Új módszer a tüdőgyógyászatban.] ' (2003 ) 144 Orv. Hetil. : 2517 -2524.

    • Search Google Scholar
  • Clary-Meinesz, C., Mouroux, J., Cosson, J., et al.: Influence of external pH on ciliary beat frequency in human bronchi and bronchioles. Eur. Respir. J., 1998, 11, 330–333.

    Cosson J. , 'Influence of external pH on ciliary beat frequency in human bronchi and bronchioles ' (1998 ) 11 Eur. Respir. J. : 330 -333.

    • Search Google Scholar
  • Antus, B., Horvath, I., Barta, I.: Assessment of exhaled nitric oxide by a new hand-held device. Respir. Med., 2010, 104, 1377–1380.

    Barta I. , 'Assessment of exhaled nitric oxide by a new hand-held device ' (2010 ) 104 Respir. Med. : 1377 -1380.

    • Search Google Scholar
  • Czebe, K., Kullmann, T., Csiszer, E., et al.: Variability of exhaled breath condensate pH in lung transplant recipients. Respiration, 2008, 75, 322–327.

    Csiszer E. , 'Variability of exhaled breath condensate pH in lung transplant recipients ' (2008 ) 75 Respiration : 322 -327.

    • Search Google Scholar
  • Kullmann, T., Barta, I., Antus, B., et al.: Drinking influences exhaled breath condensate acidity. Lung, 2008, 186, 263–268.

    Antus B. , 'Drinking influences exhaled breath condensate acidity ' (2008 ) 186 Lung : 263 -268.

    • Search Google Scholar
  • Borrill, Z., Starkey, C., Vestbo, J., et al.: Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur. Respir. J., 2005, 25, 269–274.

    Vestbo J. , 'Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease ' (2005 ) 25 Eur. Respir. J. : 269 -274.

    • Search Google Scholar
  • Kostikas, K., Papatheodorou, G., Ganas, K., et al.: PH in expired breath condensate of patients with inflammatory airway diseases. Am. J. Respir. Crit. Care Med., 2002, 165, 1364–1370.

    Ganas K. , 'PH in expired breath condensate of patients with inflammatory airway diseases ' (2002 ) 165 Am. J. Respir. Crit. Care Med. : 1364 -1370.

    • Search Google Scholar
  • Antus, B., Barta, I., Kullmann, T., et al.: Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study. Am. J. Respir. Crit. Care Med., 2010, 182, 1492–1497.

    Kullmann T. , 'Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study ' (2010 ) 182 Am. J. Respir. Crit. Care Med. : 1492 -1497.

    • Search Google Scholar
  • Kullmann, T., Barta, I., Lazar, Z., et al.: Exhaled breath condensate pH standardised for CO2 partial pressure. Eur. Respir. J., 2007, 29, 496–501.

    Lazar Z. , 'Exhaled breath condensate pH standardised for CO2 partial pressure ' (2007 ) 29 Eur. Respir. J. : 496 -501.

    • Search Google Scholar
  • Czebe, K., Barta, I., Antus, B., et al.: Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations. Respir. Med., 2008, 102, 720–725.

    Antus B. , 'Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations ' (2008 ) 102 Respir. Med. : 720 -725.

    • Search Google Scholar
  • Kullmann, T., Barta, I., Antus, B., et al.: Environmental temperature and relative humidity influence exhaled breath condensate pH. Eur. Respir. J., 2008, 31, 474–475.

    Antus B. , 'Environmental temperature and relative humidity influence exhaled breath condensate pH ' (2008 ) 31 Eur. Respir. J. : 474 -475.

    • Search Google Scholar
  • Antus, B., Barta, I.: Exhaled breath condensate pH in patients with lung cancer. Lung Cancer, 2012, 75, 178–180.

    Barta I. , 'Exhaled breath condensate pH in patients with lung cancer ' (2012 ) 75 Lung Cancer : 178 -180.

    • Search Google Scholar
  • Soter, S., Kelemen, K., Barta, I., et al.: Exhaled breath condensate pH in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation, 2011, 91, 793–797.

    Barta I. , 'Exhaled breath condensate pH in lung transplant recipients with bronchiolitis obliterans syndrome ' (2011 ) 91 Transplantation : 793 -797.

    • Search Google Scholar
  • MacNee, W., Rennard, S. I., Hunt, J. F., et al.: Evaluation of exhaled breath condensate pH as a biomarker for COPD. Respir. Med., 2011, 105, 1037–1045.

    Hunt J. F. , 'Evaluation of exhaled breath condensate pH as a biomarker for COPD ' (2011 ) 105 Respir. Med. : 1037 -1045.

    • Search Google Scholar
  • Montuschi, P., Collins, J. V., Ciabattoni, G., et al.: Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am. J. Respir. Crit. Care Med., 2000, 162, 1175–1177.

    Ciabattoni G. , 'Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers ' (2000 ) 162 Am. J. Respir. Crit. Care Med. : 1175 -1177.

    • Search Google Scholar
  • Kostikas, K., Papatheodorou, G., Psathakis, K., et al.: Oxidative stress in expired breath condensate of patients with COPD. Chest, 2003, 124, 1373–1380.

    Psathakis K. , 'Oxidative stress in expired breath condensate of patients with COPD ' (2003 ) 124 Chest : 1373 -1380.

    • Search Google Scholar
  • Biernacki, W. A., Kharitonov, S. A., Barnes, P. J.: Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax, 2003, 58, 294–298.

    Barnes P. J. , 'Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD ' (2003 ) 58 Thorax : 294 -298.

    • Search Google Scholar
  • Carpagnano, G. E., Resta, O., Foschino-Barbaro, M. P., et al.: Exhaled interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur. J. Pharmacol., 2004, 505, 169–175.

    Foschino-Barbaro M. P. , 'Exhaled interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys) ' (2004 ) 505 Eur. J. Pharmacol. : 169 -175.

    • Search Google Scholar
  • Soter, S., Barta, I., Antus, B.: Sputum biomarkers in COPD exacerbations. Eur. Respir. J., 2011, 38, 157s.

    Antus B. , 'Sputum biomarkers in COPD exacerbations ' (2011 ) 38 Eur. Respir. J. : 157s -.

  • Ko, F. W., Lau, C. Y., Leung, T. F., et al.: Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respir. Med., 2006, 100, 630–638.

    Leung T. F. , 'Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease ' (2006 ) 100 Respir. Med. : 630 -638.

    • Search Google Scholar
  • Montuschi, P., Kharitonov, S. A., Ciabattoni, G., et al.: Exhaled leukotrienes and prostaglandins in COPD. Thorax, 2003, 58, 585–588.

    Ciabattoni G. , 'Exhaled leukotrienes and prostaglandins in COPD ' (2003 ) 58 Thorax : 585 -588.

    • Search Google Scholar
  • Kostikas, K., Gaga, M., Papatheodorou, G., et al.: Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest, 2005, 127, 1553–1559.

    Papatheodorou G. , 'Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma ' (2005 ) 127 Chest : 1553 -1559.

    • Search Google Scholar
  • Borrill, Z. L., Starkey, R. C., Singh, S. D.: Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients. Int. J. Chron. Obstruct. Pulmon. Dis., 2007, 2, 71–76.

    Singh S. D. , 'Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients ' (2007 ) 2 Int. J. Chron. Obstruct. Pulmon. Dis. : 71 -76.

    • Search Google Scholar
  • Antczak, A., Piotrowski, W., Marczak, J., et al.: Correlation between eicosanoids in bronchoalveolar lavage fluid and in exhaled breath condensate. Dis. Markers, 2011, 30, 213–220.

    Marczak J. , 'Correlation between eicosanoids in bronchoalveolar lavage fluid and in exhaled breath condensate ' (2011 ) 30 Dis. Markers : 213 -220.

    • Search Google Scholar
  • Carpagnano, G. E., Foschino-Barbaro, M. P., Cagnazzo, M., et al.: Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge. Chest, 2005, 128, 3159–3166.

    Cagnazzo M. , 'Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge ' (2005 ) 128 Chest : 3159 -3166.

    • Search Google Scholar
  • Carpagnano, G. E., Kharitonov, S. A., Foschino-Barbaro, M. P., et al.: Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur. Respir. J., 2003, 21, 589–593.

    Foschino-Barbaro M. P. , 'Increased inflammatory markers in the exhaled breath condensate of cigarette smokers ' (2003 ) 21 Eur. Respir. J. : 589 -593.

    • Search Google Scholar
  • Garey, K. W., Neuhauser, M. M., Robbins, R. A., et al.: Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest, 2004, 125, 22–26.

    Robbins R. A. , 'Markers of inflammation in exhaled breath condensate of young healthy smokers ' (2004 ) 125 Chest : 22 -26.

    • Search Google Scholar
  • Gessner, C., Scheibe, R., Wötzel, M., et al.: Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir. Med., 2005, 99, 1229–1240.

    Wötzel M. , 'Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease ' (2005 ) 99 Respir. Med. : 1229 -1240.

    • Search Google Scholar
  • Antus, B., Barta, I., Czebe, K., et al.: Analysis of cytokine pattern in exhaled breath condensate of lung transplant recipients with bronchiolitis obliterans syndrome. Inflamm. Res., 2010, 59, 83–86.

    Czebe K. , 'Analysis of cytokine pattern in exhaled breath condensate of lung transplant recipients with bronchiolitis obliterans syndrome ' (2010 ) 59 Inflamm. Res. : 83 -86.

    • Search Google Scholar
  • Barta, I., Kullmann, T., Csiszer, E., et al.: Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma. Int. J. Biol. Markers, 2010, 25, 52–56.

    Csiszer E. , 'Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma ' (2010 ) 25 Int. J. Biol. Markers : 52 -56.

    • Search Google Scholar
  • Dekhuijzen, P. N., Aben, K. K., Dekker, I., et al.: Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1996, 154, 813–816.

    Dekker I. , 'Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease ' (1996 ) 154 Am. J. Respir. Crit. Care Med. : 813 -816.

    • Search Google Scholar
  • Nowak, D., Kasielski, M., Antczak, A., et al.: Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir. Med., 1999, 93, 389–396.

    Antczak A. , 'Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking ' (1999 ) 93 Respir. Med. : 389 -396.

    • Search Google Scholar
  • Gerritsen, W. B., Asin, J., Zanen, P., et al.: Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir. Med., 2005, 99, 84–90.

    Zanen P. , 'Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients ' (2005 ) 99 Respir. Med. : 84 -90.

    • Search Google Scholar
  • Kasielski, M., Nowak, D.: Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir. Med., 2001, 95, 448–456.

    Nowak D. , 'Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease ' (2001 ) 95 Respir. Med. : 448 -456.

    • Search Google Scholar
  • Van Beurden, W. J., Harff, G. A., Dekhuijzen, P. N., et al.: Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration, 2003, 70, 242–248.

    Dekhuijzen P. N. , 'Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients ' (2003 ) 70 Respiration : 242 -248.

    • Search Google Scholar
  • Ferreira, I. M., Hazari, M. S., Gutierrez, C., et al.: Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. Am. J. Respir. Crit. Care. Med., 2001, 164, 1012–1015.

    Gutierrez C. , 'Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone ' (2001 ) 164 Am. J. Respir. Crit. Care. Med. : 1012 -1015.

    • Search Google Scholar
  • Corradi, M., Montuschi, P., Donnelly, L. E., et al.: Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am. J. Respir. Crit. Care Med., 2001, 163, 854–858.

    Donnelly L. E. , 'Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases ' (2001 ) 163 Am. J. Respir. Crit. Care Med. : 854 -858.

    • Search Google Scholar
  • Lázár, Z., Huszár, E., Kullmann, T., et al.: Adenosine triphosphate in exhaled breath condensate of healthy subjects and patients with chronic obstructive pulmonary disease. Inflamm. Res., 2008, 57, 367–373.

    Kullmann T. , 'Adenosine triphosphate in exhaled breath condensate of healthy subjects and patients with chronic obstructive pulmonary disease ' (2008 ) 57 Inflamm. Res. : 367 -373.

    • Search Google Scholar
All Time Past Year Past 30 Days
Abstract Views 75 75 6
Full Text Views 17 14 0
PDF Downloads 9 6 0